TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections - News-Medical.Net

Researchers assessed the efficacy of TMPRSS2 against SARS-CoV-2 variants of concern Alpha, Beta, Gamma, and Delta, in mice and human lung cells.

In a recent study published in Nature, researchers assessed the efficacy of small molecule protease inhibitors of transmembrane serine protease 2 (TMPRSS2) against severe acute respiratory syndrome c… [+5249 chars]

full article...